CRACR2A/EFCAB4B Blocking Peptide (#BLP-CC324) is the original antigen used for immunization during Anti-CRACR2A (EFCAB4B) Antibody (#ACC-324) generation. The blocking peptide binds and ‘blocks’ Anti-CRACR2A/EFCAB4B primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
- Western blot analysis of human T cell leukemia (Jurkat) (lanes 1 and 3) and rat stomach (lanes 2 and 4) lysates:
- (C)KSEKEQFLLKDTER, corresponding to amino acid residues 245-258 of human CRACR2A (Accession Q9BSW2).